Navigation Links
Rapid venom evolution in pit vipers may be defensive
Date:7/18/2011

ausing massive internal hemorrhaging in nonresistant warm-blooded prey species, mainly rodents and birds.

The new research came out of a previous phylogenetic study of marsupials, published as a Bulletin of the American Museum of Natural History, that suggested unusually rapid evolution in one gene among a group of snake-eating opossums. The rapidly evolving gene codes for von Willebrand's factor, an important blood-clotting protein that is known to be the target of several snake-venom toxins. The association of rapid evolution in a venom-targeted gene among just those opossums known to eat pitvipers was the essential clue that prompted further study.

"This finding took us by surprise," says Sharon Jansa, associate professor in the Department of Ecology, Evolution and Behavior at the University of Minnesota and a Museum research associate. "We sequenced several genesincluding the one that codes for von Willebrand Factor (vWF)to use in a study of opossum phylogeny. Once we started to analyze the data, vWF was a real outlier. It was evolving much more rapidly than expected in a group of opossums that also, as it turns out, are resistant to pitviper venom."

The recently published research demonstrates that the rate of replacement substitutions (nucleotide changes that result in amino-acid changes) is much higher than the rate of silent substitutions (nucleotide changes that have no effect on the protein) in the von Willebrand Factor gene among pitviper-eating opossums. Typically, high rates of replacement substitutions means that the gene is under strong, sustained natural selection. That only happens in a few evolutionary circumstances.

"Most nucleotide substitutions have little or no effect on protein function, but that doesn't seem to be the case with vWF in these venom-resistant opossums," says Jansa. "The specific amino acids in vWF that interact with toxin proteins show unexpectedly high rates of replacement substitutions. These
'/>"/>

Contact: Michael Walker
walker@amnh.org
212-769-5766
American Museum of Natural History
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Study Shows Sutro Biopharmas Biochemical Protein Synthesis Technology Enables Rapid Production and Scale-Up of Biopharmaceuticals
2. Plasticity of hormonal response permits rapid gene expression reprogramming
3. University of Tennessee scientist: Flowers rapid growth rate can be traced back 65 million years
4. Genome duplication encourages rapid adaptation of plants
5. Evolution can cause a rapid reduction in genome size
6. New imaging technique provides rapid, high-definition chemistry
7. In the best youth football teams, the first team players develop their bodies more rapidly
8. Research suggests HIV causes rapid aging in key infection-fighting cells
9. New method for rapidly producing protein-polymers
10. Dana-Farber receive $5.6 million grant to develop rapid countermeasures to infectious agents
11. Microfluidic device rapidly orients hundreds of embryos for high-throughput experiments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2015)... 26, 2015 NXT-ID, Inc. (NASDAQ: NXTD ... authentication company focused on the growing mobile commerce market, ... http://www.nxt-id.com/ ) as part of its 2015 marketing and ... launched its new consumer website for Wocketwallet.com earlier this ... of NXT-ID said, "Our new corporate website naturally showcases ...
(Date:2/5/2015)... 28, 2015 Research and Markets ... the "Global Biometrics Market (2014-2020): Market Forecast ... report to their offering. , ... is anticipated to overtake ... increasing government spending towards IT security, government biometric ...
(Date:1/22/2015)... 2015 Valid S.A. ("Company") (BM&FBOVESPA: VLID3 ON), is pleased ... State of Washington,s Department of Licensing, ... and central issuance system for driver,s licenses and identification cards ... planning and development will start in January 2015, with enrollment ...
Breaking Biology News(10 mins):NXT-ID, Inc. Launches New Corporate Website As Part Of Ongoing 2015 Branding Initiatives For Wocket Smart Wallet 2NXT-ID, Inc. Launches New Corporate Website As Part Of Ongoing 2015 Branding Initiatives For Wocket Smart Wallet 3Global Biometrics Market (2014-2020): Market Forecast By Technologies, Applications, End Use, Regions and Countries 2Global Biometrics Market (2014-2020): Market Forecast By Technologies, Applications, End Use, Regions and Countries 3Valid USA Signs Contract For Washington Driver's License Issuance 2
... even those caused by antibiotic-sensitive bacteria, resist treatment. This ... impossible to cure. A key cause of this ... Starved bacteria resist killing by nearly every type of ... What produces starvation-induced antibiotic resistance, and how ...
... While shorter days and colder weather move many ... spent their summers in fieldwork are more likely to ... samples and crunching data from their summer,s labors. ... spent a month last summer in Mexico,s Sea of ...
... Although scientists have known for centuries that many bacteria produce ... toxic by-product of cellular activity. Now, researchers at NYU ... major role in protecting bacteria from the effects of numerous ... Nudler, PhD, the Julie Wilson Anderson Professor of Biochemistry at ...
Cached Biology News:What bacteria don't know can hurt them 2What bacteria don't know can hurt them 3Squid mystery in Mexican waters unraveled by Stanford biologist and a class of students 2Squid mystery in Mexican waters unraveled by Stanford biologist and a class of students 3Squid mystery in Mexican waters unraveled by Stanford biologist and a class of students 4Targeting bacterial gas defenses allow for increased efficacy of numerous antibiotics 2
(Date:2/27/2015)... , Feb. 27, 2015  Pfenex Inc. (NYSE ... development of biosimilar therapeutics, today announced that it will ... Marriott Marquis on March 2 nd at 3pm ... on a panel discussing the current state of the ... Biosimilars . For more information on ...
(Date:2/27/2015)... South San Francisco, CA (PRWEB) February 27, 2015 ... it is joining forces on February 28 with patients ... globally to raise awareness for Rare Disease Day®. ... of rare diseases and calling attention to the special ... support community around them. , “Cytokinetics is proud to ...
(Date:2/27/2015)... PureTech , a science and technology R&D company focused  ... in the healthcare sector, announced today the appointment of ... the Board of Directors of Sanofi, to its Board ... pleasure to know Chris for many years and I ... more closely now," said Dr. Robert Langer , ...
(Date:2/26/2015)... Feb. 26, 2015 On behalf of biotech ... companies, Wilentz, Goldman & Spitzer, P.A. (Wilentz) ... against Genewiz Inc. in excess of $10 million. The ... trade secrets, and that it improperly hired one or ... denying motions for judgment notwithstanding the verdict, a new ...
Breaking Biology Technology:Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 2Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 3Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 4Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 5Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 6Christopher Viehbacher, former CEO of Sanofi, Joins PureTech's Board of Directors 2Christopher Viehbacher, former CEO of Sanofi, Joins PureTech's Board of Directors 3Christopher Viehbacher, former CEO of Sanofi, Joins PureTech's Board of Directors 4Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 2Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 3
... years of cumulative expertise ... ... Tobira,Therapeutics Inc., a clinical stage biotechnology company committed to the,research and product ... company,s,senior management team. Tobira Therapeutics has been led since its,inception in 2006 ...
... Today at 1:00 pm ET / 10:00 am ... Anesiva,Inc. (Nasdaq: ANSV ) today announced ... (lidocaine hydrochloride monohydrate) powder,intradermal injection system. Zingo is ... associated with peripheral,intravenous (IV) line placements and blood ...
... June 30 ADVENTRX Pharmaceuticals,Inc. (Amex: ANX ... with,Theragenex, LLC and its Chairman and President and ... the Company has received,in full. The parties have ... action and all related claims and counterclaims, with,prejudice. ...
Cached Biology Technology:Tobira Therapeutics Inc. Announces Senior Management Team 2Tobira Therapeutics Inc. Announces Senior Management Team 3Anesiva Launches Needle-Free Zingo(TM) to Reduce Pain from IV Starts and Blood Draws in Children 2Anesiva Launches Needle-Free Zingo(TM) to Reduce Pain from IV Starts and Blood Draws in Children 3Anesiva Launches Needle-Free Zingo(TM) to Reduce Pain from IV Starts and Blood Draws in Children 4Anesiva Launches Needle-Free Zingo(TM) to Reduce Pain from IV Starts and Blood Draws in Children 5ADVENTRX Settles Dispute With Former Licensee 2
Human ICAT Affinity Purified Polyclonal Ab...
... Mouse monoclonal [APS 26] to Presenilin 2 ... inherited form of the disease carry mutations ... the amyloid precursor protein (APP). These disease-linked ... longer form of amyloid-beta (main component of ...
assays for phosphatase, lipase, nucleoside triphosphatases (ATPase, GTPase etc). HTS and follow up studies for phosphatase inhibitors. Quantitation of phosphate content in protein, lipids, and DNA....
One-step, microplate or cuvet, turbidometric, linear detection range 0.096 mg/dL to 11.5 mg/dL. Procedure: 5 min....
Biology Products: